Head and neck paragangliomas in Norway, importance of genetics, updated diagnostic workup and treatment
Open Access
- 1 March 2021
- journal article
- research article
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 141 (3) , 303-308
Abstract
Background Head and neck paragangliomas (HNPG) are rare and predominantly benign tumours, originating from the neuroendocrine paraganglionic system. A considerable proportion of HNPGs are hereditary, depending on the population. Aims/objectives The purpose of this study was to estimate the rate of hereditary HNPGs in a Scandinavian (Norwegian) population, report long-term experience with HNPGs and offer all patients diagnosed an updated follow-up, with emphasis on identifying hereditary HNPGs through genetic screening and multifocality by 18 F-2-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT). Material and methods Our study was a partly retrospective and partly prospective cohort study. It included patients with HNPG diagnosed at Oslo University Hospital (OUH), Rikshospitalet between 1990 and 2017. The patients underwent genetic testing, F-18-FDG PET/CT and measurement of catecholamines and meta-nephrines in the plasma. All resection specimens and biopsies were subjected to histopathological review. The genetic testing protocol consisted of testing for mutations in the following genes; SDHD, SDHB, SDHC, VHL and RET. Results Sixty-three patients were included in the study with a median age of 49 years (range 12 - 80). Cranial nerve dysfunction was present upon diagnosis in 13%, and 14% had multifocal paraganglioma (PG) disease. Fifty-six patients (89% of all the patients) underwent genetic testing, and 29% of these had a PG related mutation. Seven of the eight patients (88%) with multifocal PGs who underwent genetic testing had a mutation. In two of the patients, the F-18-FDG PET/CT revealed unknown and subclinical multifocality. Conclusions and significance This is the first study with systematic genetic workup and PET/CT imaging in Scandinavia of HNPG patients. The mutation rate was within the lower range reported in the literature with respect to HNPGs. Combining genetic testing and PET/CT imaging in the diagnostic workup of HNPGs is valuable.Keywords
This publication has 19 references indexed in Scilit:
- Genetics of hereditary head and neck paragangliomasHead & Neck, 2013
- Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission TomographyJNCI: Journal of the National Cancer Institute, 2012
- Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapyHead & Neck, 2012
- Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patientsClinical Endocrinology, 2011
- The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine TumorsPancreas, 2010
- 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine TumorsClinical Cancer Research, 2010
- Malignant Head and Neck Paragangliomas in SDHB Mutation CarriersOtolaryngology–Head and Neck Surgery, 2007
- Paragangliomas of the head and neck: diagnosis and treatmentFamilial Cancer, 2005
- Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomasJournal of Medical Genetics, 2002
- National Cancer Data Base report on malignant paragangliomas of the head and neckCancer, 2002